Cancer Study in Dogs

Canine Health Foundation News Alert
Van Andel Research Institute Launches New Canine Cancer Studies! Your Participation is Needed in the Collection of Tumor Samples [Tuesday, June 15, 2010]

The Van Andel Research Institute, in Grand Rapids, Michigan, received a “Grand Opportunities” (GO grant) from the National Institutes of Health. This is enabling the Institute to expand its canine cancer studies, which started with a project partially funded by the Canine Health Foundation investigating hemangiosarcoma in Clumber Spaniels 18 months ago, into a much broader research program. They are launching a new center of excellence in canine genetics and genomics. The first and most important program is the Canine Hereditary Cancer Consortium (CHCC), which is headed by Drs. Jeff Trent (TGen), Nick Duesbery (Van Andel Research Institute), and Paul Meltzer (National Cancer Institute/NIH) . The program is an unprecedented alliance of scientists, veterinarians and physicians. Drs. Duesbery and Froman are intensely focused on recruiting canine cancer patients for the study through a variety of clinical outreach programs. Samples from canine patients will not only allow the researchers to identify genes responsible for breed-specific susceptibilities (such as hemangiosarcoma in Clumber Spaniels and osteosarcoma in Greyhounds), but also to translate these discoveries into new and more precise diagnostics and therapeutics for both canine and human cancer patients. The ultimate goal is to take personalized medicine for dogs to unscaled heights!

You can find more information about this program in  found in the 31st issue of Discoveries, the Canine Health Foundation newsletter.

Read more